Barclays Portfolio holdings
Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amazon
AMZN
|
+$1.19B |
| 2 |
Microsoft
MSFT
|
+$1.07B |
| 3 |
Alphabet (Google) Class A
GOOGL
|
+$1.06B |
| 4 |
Tesla
TSLA
|
+$1.01B |
| 5 |
Meta Platforms (Facebook)
META
|
+$691M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street Technology Select Sector SPDR ETF
XLK
|
+$689M |
| 2 |
Invesco QQQ Trust
QQQ
|
+$525M |
| 3 |
ALXN
Alexion Pharmaceuticals
ALXN
|
+$450M |
| 4 |
KSU
Kansas City Southern
KSU
|
+$305M |
| 5 |
iShares MSCI EAFE ETF
EFA
|
+$265M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 14.37% |
| 2 | Financials | 9.02% |
| 3 | Communication Services | 7.25% |
| 4 | Consumer Discretionary | 6.95% |
| 5 | Healthcare | 6.71% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
PTR
3226
DELISTED
PETROCHINA COMPANY LIMITED ADS (REP 100 H SHARES)
PTR
| $444K | ﹤0.01% |
9,488
-2,272
| -19% | -$100K |
|
3227
Heritage Insurance Holdings
HRTG
$889M
| $443K | ﹤0.01% |
65,033
+10,697
| +20% | +$77K |
|
3228
iShares MBS ETF
MBB
$38.9B
| $442K | ﹤0.01% |
4,086
-935,966
| -100% | -$102M |
|
3229
United Fire Group
UFCS
$1.32B
| $442K | ﹤0.01% |
19,094
+7,893
| +70% | +$197K |
|
3230
Blue Bird Corp
BLBD
$2.35B
| $438K | ﹤0.01% |
20,961
+8,488
| +68% | +$188K |
|
3231
Oil States International
OIS
$489M
| $438K | ﹤0.01% |
68,625
+36,753
| +115% | +$221K |
|
3232
CALL
Kroger
KR
$35.4B
| $437K | ﹤0.01% |
10,800
-1,600
| -13% | -$67.2K |
|
|
EXTN
3233
DELISTED
Exterran Corporation
EXTN
| $436K | ﹤0.01% |
98,232
-20,430
| -17% | -$86.7K |
|
|
LKFT
3234
Lakefront Biotherapeutics American Depositary Shares
LKFT
$1.78B
| $435K | ﹤0.01% |
8,261
| – | – |
|
3235
Theravance Biopharma
TBPH
$874M
| $435K | ﹤0.01% |
58,790
+51,922
| +756% | +$581K |
|
|
ATRI
3236
DELISTED
Atrion Corp
ATRI
| $434K | ﹤0.01% |
622
+352
| +130% | +$234K |
|
3237
Precision BioSciences
DTIL
$180M
| $432K | ﹤0.01% |
1,248
+1,022
| +452% | +$346K |
|
3238
Entravision Communication
EVC
$1.03B
| $431K | ﹤0.01% |
60,698
+17,556
| +41% | +$119K |
|
3239
V2X
VVX
$2.83B
| $431K | ﹤0.01% |
8,576
+7,114
| +487% | +$336K |
|
3240
Axogen
AXGN
$2.27B
| $429K | ﹤0.01% |
27,088
+10,841
| +67% | +$195K |
|
|
XRN
3241
Chiron Real Estate Inc
XRN
$514M
| $429K | ﹤0.01% |
5,833
+182
| +3% | +$13.9K |
|
|
BCOV
3242
DELISTED
Brightcove, Inc.
BCOV
| $429K | ﹤0.01% |
37,127
+22,430
| +153% | +$271K |
|
3243
National Presto Industries
NPK
$870M
| $427K | ﹤0.01% |
5,206
+943
| +22% | +$84.6K |
|
3244
Colliers International
CIGI
$5.04B
| $426K | ﹤0.01% |
3,333
+1,029
| +45% | +$131K |
|
3245
Arlo Technologies
ARLO
$1.6B
| $425K | ﹤0.01% |
66,326
+23,547
| +55% | +$146K |
|
3246
DXP Enterprises
DXPE
$2.43B
| $425K | ﹤0.01% |
14,379
+5,178
| +56% | +$159K |
|
3247
Ultragenyx Pharmaceutical
RARE
$2.45B
| $425K | ﹤0.01% |
4,715
-19,665
| -81% | -$1.78M |
|
3248
REX American Resources
REX
$1.42B
| $425K | ﹤0.01% |
31,956
+15,366
| +93% | +$208K |
|
3249
Energy Fuels
UUUU
$2.86B
| $424K | ﹤0.01% |
60,401
+42,188
| +232% | +$240K |
|
3250
Teucrium Corn Fund
CORN
$176M
| $423K | ﹤0.01% |
20,979
+15,372
| +274% | +$310K |
|
Similar funds
Barclays's Q3 2021 Portfolio in Review
As of Q3 2021, Barclays held 5,157 positions worth $222B, up 5% from $212B the previous quarter. Its ten largest holdings account for 31% of the portfolio.
Barclays deployed $12.8B of net new capital in Q3 2021, opening 259 new positions and adding to 2,650 existing holdings. Its largest new stake was Invesco Zacks Mid-Cap ETF: 700,000 shares worth $62.9M.
By sector, the portfolio is most concentrated in Technology at 14% of assets, up from 13% a quarter earlier, followed by Financials and Communication Services.
On the sell side, the largest reduction was State Street Technology Select Sector SPDR ETF, an estimated $689M trimmed.
- Barclays's largest Q3 2021 buy was Invesco Zacks Mid-Cap ETF: 700,000 shares worth $62.9M.
- Barclays added most to Amazon in Q3 2021, an estimated $1.19B increase.
- Barclays's biggest Q3 2021 reduction was State Street Technology Select Sector SPDR ETF, cutting an estimated $689M.
- Barclays fully exited GE Aerospace in Q3 2021, selling an estimated $248M.
- Barclays's ten largest holdings make up 31% of its $222B portfolio in Q3 2021.
- Barclays opened 259 new positions and closed 365 in Q3 2021.
- Barclays's portfolio value rose 5% quarter-over-quarter to $222B.
Based on Barclays's 13F filing for Q3 2021, filed 9 Nov 2021.